financetom
Business
financetom
/
Business
/
Market Chatter: Blackstone Selling Senior Housing Portfolio at Heavy Losses
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Blackstone Selling Senior Housing Portfolio at Heavy Losses
Nov 7, 2025 12:54 PM

03:31 PM EST, 11/07/2025 (MT Newswires) -- Blackstone (BX) is offloading a $1.8 billion senior housing portfolio at steep losses after the investment underperformed, the Wall Street Journal reported Friday, citing public records and people familiar with the matter.

The firm has sold about 70 of the roughly 90 properties since 2022, often at more than 70% below the original purchase price, the report added.

According to the Journal's review, 39 properties bought for over $755 million were or are being sold for around $536 million, reflecting a 29% decline in value.

Five properties reportedly sold for less than the outstanding loan amounts, and more than a dozen were cited for care-related deficiencies by regulators.

Rising interest rates and labor costs, coupled with floating-rate debt, pushed many of the properties into financial trouble, including two dozen loans that went into special servicing earlier this year.

"These properties sit in a $33.5 billion fund that has nearly doubled investors capital," Blackstone said in a statement to MT Newswires. "These properties, like much of the senior housing sector, were significantly impacted by COVID."

"Importantly, Blackstone's commitment to residents and the frontline workers who care for them has never wavered, as evidenced by over $100 million in improvements and operational investments made to these communities," Blackstone added in its statement.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 145.67, Change: +2.24, Percent Change: +1.56

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BofA clinches record number of patents with AI, information security in focus
BofA clinches record number of patents with AI, information security in focus
Mar 6, 2024
NEW YORK (Reuters) - Bank of America ( BAC ) secured a record 644 U.S. patents in 2023, up 13% from the previous year, as the lender focused on information security, artificial intelligence (AI) and machine learning, it said on Wednesday. The second-largest U.S. lender now has 6,600 granted patents or pending applications worldwide, including more than 800 related to...
OpenAI seeks to dismiss Musk claims, says billionaire pushed for merger with Tesla
OpenAI seeks to dismiss Musk claims, says billionaire pushed for merger with Tesla
Mar 6, 2024
March 5 (Reuters) - OpenAI on Tuesday rejected Elon Musk's claims that the startup had abandoned its original mission of developing artificial intelligence for the benefit of humanity, and said the billionaire had demanded a merger between the ChatGPT-maker and Tesla. OpenAI said in a blog post it intends to move to dismiss all of Musk's claims. Musk filed a...
Analog Devices, BMW Collaborating to Enable Software-Defined Vehicles
Analog Devices, BMW Collaborating to Enable Software-Defined Vehicles
Mar 6, 2024
09:14 AM EST, 03/06/2024 (MT Newswires) -- Analog Devices ( ADI ) and the BMW Group said Wednesday they are collaborating for the early adoption of ADI's 10BASE-T1S ethernet to the edge technology to enable software-defined vehicles. BMW will be the main original equipment manufacturer to implement the technology in automotive, the companies said. Financial details of the collaboration were...
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
Mar 6, 2024
Tuesday, the FDA approved DexCom Inc’s Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM).  The Dexcom Stelo Glucose Biosensor System is an integrated CGM (iCGM) intended for anyone 18 years and older who does not use insulin. The company said Stelo will be available online without a prescription starting summer of 2024. This system is not for individuals with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved